July 2, 2021

Covid first wave led to increase in antibiotic misuse in India: Study

PhotoCredit: nationalheraldindia

The misuse of drugs is considered inappropriate because antibiotics are only effective against bacterial infections, not viral infections such as COVID-19, said the study

Washington: Antibiotic sales soared during the first COVID-19 wave in India last year, according to a study which suggests that the drugs were used to treat mild and moderate cases of the viral disease.

The researchers at Washington University in the US estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses of azithromycin in adults from June 2020 through September 2020, a period of peak COVID-19 activity in India.

Such misuse of drugs is considered inappropriate because antibiotics are only effective against bacterial infections, not viral infections such as COVID-19, the researchers said.

Overuse of antibiotics increases the risk for drug-resistant infections, they said.

“Antibiotic resistance is one of the greatest threats to global public health,” said the study’s senior author, Sumanth Gandra, an associate hospital epidemiologist at Barnes-Jewish Hospital in the US.

“Overuse of antibiotics lessens their ability to effectively treat minor injuries and common infections such as pneumonia, which means that these conditions can become serious and deadly,” Gandra said.

The study, published in the journal PLOS Medicine, analysed monthly sales of all antibiotics in India’s private health sector from January 2018 through December 2020.

The data came from an Indian branch of IQVIA, a U.S.-based health information technology company.

The study, conducted in collaboration with McGill University in Canada, examined the total sales volume of all antibiotics as well as the individual sales for azithromycin, a vital drug for treating typhoid fever, non-typhoidal Salmonella and traveller’s diarrhoea.

Azithromycin was studied because some countries experienced a spike in its sales early in the pandemic after observational studies suggested the antibiotic could help treat COVID-19.

However, such a claim was disputed by subsequent studies.

The researchers determined that a total of 16.29 billion doses of antibiotics were sold in India in 2020, which is slightly less than the amounts sold in 2018 and in 2019.

However, when researchers focused on adult doses, usage increased from 72.6 per cent in 2018 and 72.5 per cent in 2019 to 76.8 per cent in 2020.

Additionally, sales of azithromycin for adults in India increased from 4 per cent in 2018 and 4.5 per cent in 2019 to 5.9 per cent in 2020.

The study also showed notable increases in the sales of doxycycline and faropenem, two antibiotics commonly used to treat respiratory infections.

The researchers used previously published studies to compare India’s antibiotic use with that in the US and other high-income countries.

In those countries, they found that adult antibiotic use decreased drastically during the pandemic compared with such use in 2018 and 2019.

“It’s critical to acknowledge that antibiotic use in high-income countries plummeted in 2020,” Gandra said.

Also Read: Assam: 3 arrested in connection with death of over 200 egrets at Tangla

The study, published in the journal PLOS Medicine, analysed monthly sales of all antibiotics in India’s private health sector from January 2018 through December 2020.

The data came from an Indian branch of IQVIA, a U.S.-based health information technology company.

The study, conducted in collaboration with McGill University in Canada, examined the total sales volume of all antibiotics as well as the individual sales for azithromycin, a vital drug for treating typhoid fever, non-typhoidal Salmonella and traveller’s diarrhoea.

Azithromycin was studied because some countries experienced a spike in its sales early in the pandemic after observational studies suggested the antibiotic could help treat COVID-19.

However, such a claim was disputed by subsequent studies.

The researchers determined that a total of 16.29 billion doses of antibiotics were sold in India in 2020, which is slightly less than the amounts sold in 2018 and in 2019.

However, when researchers focused on adult doses, usage increased from 72.6 per cent in 2018 and 72.5 per cent in 2019 to 76.8 per cent in 2020.

Additionally, sales of azithromycin for adults in India increased from 4 per cent in 2018 and 4.5 per cent in 2019 to 5.9 per cent in 2020.

The study also showed notable increases in the sales of doxycycline and faropenem, two antibiotics commonly used to treat respiratory infections.

The researchers used previously published studies to compare India’s antibiotic use with that in the US and other high-income countries.

In those countries, they found that adult antibiotic use decreased drastically during the pandemic compared with such use in 2018 and 2019.

“It’s critical to acknowledge that antibiotic use in high-income countries plummeted in 2020,” Gandra said.

“People isolated, schools and offices closed, and fewer people got the flu and, overall, stayed healthier compared with the pre-pandemic years. This reduced the overall need for antibiotics, as did cancelling dental procedures and outpatient surgeries,” he said.

The researchers noted that India also had restrictions and experienced dramatic decreases in malaria, dengue, chikungunya and other infections typically treated with antibiotics.

“Antibiotic use should have gone down, but it didn’t. Not only that but antibiotic use increased along with the rise of COVID cases,” Gandra added.

The researchers statistically adjusted antibiotic use for seasonality and mandatory lockdown periods.

They estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics for adults and 38 million excess doses of azithromycin for adults from June 2020 through September 2020, a four-month period of peak COVID-19 activity in India.

“Our results indicate that almost everybody who was diagnosed with COVID-19 received an antibiotic in India,” Gandra added.

You may also like

July 30, 2021
Welcome to the club: Boxing pioneers Vijender, Mary Kom wish Lovlina

Vijender was the first Indian male boxer to win an Olympic medal in 2008, Mary Kom became the first woman to finish on podium in 2012 London edition. New Delhi: “Welcome to the club,” said the trailblazers of Indian boxing Vijender Singh and MC Mary Kom as they celebrated Lovlina Borgohain being assured of an Olympic […]

July 30, 2021
CM advocates drugs rehabilitation policy for Assam

CM Himanta Biswa Sarma said, "Even as we step up our fight against drugs, & tighten grip around perpetrators of this crime, there is a need to look ahead." Guwahati: Assam Chief Minister Himanta Biswa Sarma on Thursday advocated formulation of a drugs rehabilitation policy for the state and directed the health and social welfare department […]

July 30, 2021
Assam’s Lovlina Borgohain assures India of first boxing medal at Tokyo Olympics

The 23-year-old Assam boxer prevailed 4-1 to make the last-four where she will square off against reigning world champion Busenaz Surmeneli of Turkey, who hammered Ukraine's Anna Lysenko in her quarterfinal bout. Tokyo: Debutant Lovlina Borgohain (69kg) assured India of their first boxing medal at the ongoing Olympic Games when she upstaged former world champion Nien-Chin Chen of […]

July 23, 2021
Bhageerathi Amma, the oldest equivalency course student passes away

Bhageerathi Amma returned to studies in 2019 and cleared her papers as a 105-year-old student Bhageerathi Amma, the oldest equivalency course student from Kerala, passed away at Prakkulam due to age-related ailments. A recipient of the Nari Shakti Puraskar, country's highest civilian honour for women, she was 107 when she died. She had cleared Class […]

Get The latest news, opinion and much more from north east part of India and India on Midage

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram